European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

References

• Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage [Guideline no. 17]. London, UK; 2011
   Google Scholar
• Indonesian Obstetric and Gynecological Society (HIFERI-POGI). Methodological guidelines for recurrent miscarriage. Jakarta; 2011
   Google Scholar
• Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Progesterone support of the luteal phase and the first trimester. 2013. Available from: http://www.ranzcog.edu.au/doc/progesterone-support-of-the-luteal-phase-and-early-pregnancy.html
   Google Scholar
• Practice Committee of American Society of Reproductive Medicine (ASRM). Definition of infertility and recurrent pregnancy loss. Fertil Steril 2013;99:63
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence (NICE) Clinical Guideline 154. Ectopic pregnancy and miscarriage. December 2012. Available from: http://guidance.nice.org.uk/cg154
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Miscarriage Clinical Knowledge Summaries. July 2013. Available from: http://cks.nice.org.uk/miscarriage
   Google Scholar
• Saudi Society of Obstetrics and Gynecology Guidelines (SOGS). National Guidelines for prevention and treatment of miscarriages. Saudi J Obstet Gynecol 2014;15:40–63
   Google Scholar
• Coppola PT, Coppola M. Vaginal bleeding in the first 20 weeks of pregnancy. Emerg Med Clin North Am 2003;21:667–77
   PubMed Web of Science ®Google Scholar
• Schindler AE. First trimester endocrinology: consequences for diagnosis and treatment of pregnancy failure. Gynecol Endocrinol 2004;18:51–7
   PubMed Web of Science ®Google Scholar
• Schindler AE. Progestogens for treatment and pregnancy disorders. Horm Mol Biol Clin Invest 2010;3:453–460
   Google Scholar
• Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the ‘black box' of early pregnancy loss. Hum Reprod Update 2002;8:333–43
   PubMed Web of Science ®Google Scholar
• Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997;351:32–4
   Google Scholar
• Blois SM, Joachim R, Kandil J, et al. Debletion of CD8+Cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 profile. J Immunology 2004;172:5893–9
   PubMed Web of Science ®Google Scholar
• Wahabi HA, Abed Althagafi NF, Elawad M. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev 2007;18:CD005943
   Google Scholar
• Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev 2011;12:CD005943
   PubMedGoogle Scholar
• Gerhard I, Gwinner B, Eggert-Kruse W, Runnebaum B. Double-blind controlled trial of progesterone substitution in threatened abortion. Bio Res Preg Perinatol 1987;8:26–34
   PubMedGoogle Scholar
• Palagiano A, Bulletti C, Pace MC, et al. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Ann NY Acad Sci 2004;1034:200–10
   PubMed Web of Science ®Google Scholar
• El-Zibdeh MY, Yousef LT. Dydrogesterone support in threatened miscarriage. Maturitas 2009;65:S43–6
   PubMed Web of Science ®Google Scholar
• Pandian RU. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas 2009;65:S47–50
   PubMed Web of Science ®Google Scholar
• Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol 2012;28:983–90
   PubMed Web of Science ®Google Scholar
• Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2013;10:CD003511
   PubMed Web of Science ®Google Scholar
• El-Zibdeh MY. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol 2005;97:431–4
   PubMed Web of Science ®Google Scholar
• MacDonald RR, Goulden R, Oakey RE. Cervical mucus, vaginal cytology and steroid excretion in recurrent abortion. Obstet Gynecol 1972;40:394–402
   PubMed Web of Science ®Google Scholar
• Kumar A, Begum N, Prasad S, et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril 2014;102:1357–1363
   Google Scholar